ArticleFrontiers in medicine2019
Critical Review of European Health-Economic Guidelines for the Health Technology Assessment of Medical Devices.
Article in Frontiers in medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed, 3 syntheses or guidelines pooled it, 48 citations in OpenAlex.
- Methodologies for generating and evaluating clinical and performance evidence for high-risk and innovative medical devices andFrontiers in medical technology · 2026Pooled it
- Domains and Methods of Medical Device Technology Evaluation: A Systematic Review.Public health reviews · 2024Pooled it
- A systematic review of discounting in national health economic evaluation guidelines: healthcare value implications.Journal of comparative effectiveness research · 2023Pooled it
- Electrochemical liquid biopsy across cancer care pathway.The journal of liquid biopsy · 2026Review
- The Health and Productivity Impact of Thyroid Diseases Among Working-Age Women in Western Europe.International journal of women's health · 2026Article
- The Development of a New Approach for the Harmonized Multi-Sectoral and Multi-Country Cost Valuation of Services: The PECUNIA Reference Unit Cost (RUC) Templates.Applied health economics and health policy · 2024Article
- Are Medical Device Characteristics Included in HTA Methods Guidelines and Reports? A Brief Review.Applied health economics and health policy · 2024Review
- Assessing medical devices: a qualitative study from the validate perspective.International journal of technology assessment in health care · 2024Article
- Which value aspects are relevant for the evaluation of medical devices? Exploring stakeholders' views through a Web-Delphi process.BMC health services research · 2023Article
- The Challenges in Conducting Economic Evaluations for Rehabilitation Technologies.Topics in spinal cord injury rehabilitation · 2023Review
- How can health technology assessment support our response to public health emergencies?Health research policy and systems · 2022Article
- Health technology assessment of medical devices: current landscape, challenges, and a way forward.Cost effectiveness and resource allocation : C/E · 2022Review
- Patent "Evergreening" of Medicine-Device Combination Products: A Global Perspective.Healthcare policy = Politiques de sante · 2022Article
- Implementation of coverage with evidence development schemes for medical devices: A decision tool for late technology adopter countries.Health economics · 2022Article
- Implications of Oncology Trial Design and Uncertainties in Efficacy-Safety Data on Health Technology Assessments.Current oncology (Toronto, Ont.) · 2022Review
- Assessing, Pricing and Funding Point-of-Care Diagnostic Tests for Community-Acquired Acute Respiratory Tract Infections-Overview of Policies Applied in 17 European Countries.Antibiotics (Basel, Switzerland) · 2022Article
- Evidence-based funding of new imaging applications and technologies by Medicare in Australia: How it happens and how it can be improved.Journal of medical imaging and radiation oncology · 2022Article
- Critical Factors and Economic Methods for Regulatory Impact Assessment in the Medical Device Industry.Risk management and healthcare policy · 2022Review
- Broadening the application of health technology assessment in the Netherlands: a worthwhile destination but not an easy ride?Health economics, policy, and law · 2021Article
- Which multi-attribute utility instruments are recommended for use in cost-utility analysis? A review of national health technology assessment (HTA) guidelines.The European journal of health economics : HEPAC : health economics in prevention and care · 2020Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.